Abstract:Objective The ALKBH2 gene is highly expressed in urothelial tumors,and RNA interference( RNAi) technology cannot downregulate the target genes stably. The aim of this study was to construct and identify a lentiviral vector for RNA interference of human ALKBH2( ABH2). Methods The coding region of the ABH2 gene sequences were analyzed for a single-stranded oligo design and synthesis. PCR was performed for splicing reaction of synthetic oligo,which was synthesized into the pcDNA3. 1( +) vector and transformed into the competent cell DH5α. An expression vector pcDNA3. 1( +) / ABH2 was constructed after sequencing and identifying the gene sequence of the recombinant clones. According to the target gene sequence,three pairs of shRNA were designed and synthesized and built into the U6 carrier. The shRNA vectors were co-transfected with expression vectors into the HEK-293 cell line,and the optimal interference sequence was screened by QPCR. The screened shRNA-571,as the most effective interference sequence,was constructed into the lentiviral vector,pL / shRNA / F carrier. The 293T cells were co-transfected with the constructed lentiviral interference vectors and packaging plasmids,the viruses were packed,the virus stock was collected and concentrated by ultracentrifugation,and the titer of the viruses was determined. The LV-shRNA-57 was co-transfected with the over-expression vector pcDNA3. 1( +) /ABH2 into ACHN renal carcinoma,and the optimal interference sequence was screened by QPCR. Results Gene sequencing proved that the recombinant clone gene sequence was correct,and the lentiviral vector was successfully constructed. The titer of the concentrated virus was 1. 1 × 108TU / mL in the viral supernatant of 293T cells collected at 48 hours after co-transfection. The relative expression of ABH2 mRNA was significantly reduced in the siRNA-571 group after RNAi as compared with that in the control group( 0. 078 ± 0. 006 vs 0. 785 ± 0. 082,P 0. 01). The interference efficiency of the lentiviral vector PL / shRNA / F-ALKBH2-571 in the target gene ABH2 was 92. 2%. Conclusion A lentiviral RNAi expression vector targeting the ABH2 gene was successfully constructed and identified.

Construction and identification of the recombinant cell line over-expressing ABCC2 gene

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

Establishment of Over-Expressing ERCC1 Protein Cell Line

Construction and Identification of Eukaryotic Expression Vector Pcdna3.1 (+)-ABCG2

Construction of multidrug resistance hepatocellular carcinoma cell model

Construction and Expression of Enkaryotic Expression Vector Pcdna3.0/ Mbcl-2Α and in Vitro Study on L929 Cells Transfected with Pcdna3.0/ Mbcl-2Α

Construction and evaluation of the SV40-LT and hTERT overexpression MDCK cell lines

Construction and Identification of a Lentiviral RNAi Expression Vector Targeting the ALKBH2 Gene

Construction of Eukaryotic Expressing Vector of Human TLT-2 and Establishment of Stable Transfectant L929 Cell Line

Expression and Function Study of Multidrug Resistance Gene 1 in CHO Cells

Establishment of double-transfected MDCK Ⅱ cells expressing human organic anion transporting polypeptide 1B1 and multidrug resistance-associated protein 2 and identification of its functions

Construction and identification of multi-drug resistance gene-adenovirus recombinant expression vector

Establishment of Human Multidrug Resistant Hepatocarcinoma Cell Line Transfected Human Multidrug Resistance-Associated Protein Gene and Its Biological Features

Construction of an Angiopoietin-Like Protein 2 Expression Vector and Its Expression in Human Endothelial Cells

Construction of CCNL1 Eukaryotic Expression Vector and Identification of Expression of CCNL1 in MDA-MB-231 Cells

Construction of the recombinant lentiviral vector containing human ANXA2 gene and its expression in hepatocellular carcinoma cells

Construction of Expressing Vector of Psuper-Shrna/mrp1 and Its Expression in Vitro

Construction and identification of PC12 ceIIs with overexpressed CBS

[Construction and Identification of Mdr-1-shRNA Eukaryotic Expression Vector].

[Construction of Eukaryotic Expression Vector of Murine Chemokine (C-C Motif) Receptor 2 (ccr2) and Establishment of Its Stably Transfected RAW264.7 Cell Line].

Construction and Identification of FRT Cell Line Stably Expressing UT-A2